These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33461916)

  • 1. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Colchicine in Coronary Artery Disease.
    Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine and plaque: A focus on atherosclerosis imaging.
    Aldana-Bitar J; Golub IS; Moore J; Krishnan S; Verghese D; Manubolu VS; Benzing T; Ichikawa K; Hamal S; Kianoush S; Anderson LR; Ramirez NR; Leipsic JA; Karlsberg RP; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():68-75. PubMed ID: 38423236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the Role of Colchicine in Cardiovascular Disease.
    Banco D; Mustehsan M; Shah B
    Curr Cardiol Rep; 2024 Apr; 26(4):191-198. PubMed ID: 38340273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
    Zhang FS; He QZ; Qin CH; Little PJ; Weng JP; Xu SW
    Acta Pharmacol Sin; 2022 Sep; 43(9):2173-2190. PubMed ID: 35046517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine in ischemic heart disease: the good, the bad and the ugly.
    D'Amario D; Cappetta D; Cappannoli L; Princi G; Migliaro S; Diana G; Chouchane K; Borovac JA; Restivo A; Arcudi A; De Angelis A; Vergallo R; Montone RA; Galli M; Liuzzo G; Crea F
    Clin Res Cardiol; 2021 Oct; 110(10):1531-1542. PubMed ID: 33713178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine for the treatment of coronary artery disease.
    Aimo A; Pascual-Figal DA; Barison A; Cediel G; Vicente ÁH; Saccaro LF; Emdin M; Bayes-Genis A
    Trends Cardiovasc Med; 2021 Nov; 31(8):497-504. PubMed ID: 33096241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy.
    Li Y; Zhang Y; Lu J; Yin Y; Xie J; Xu B
    J Cell Mol Med; 2021 Sep; 25(17):8087-8094. PubMed ID: 34312998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation.
    Meyer-Lindemann U; Mauersberger C; Schmidt AC; Moggio A; Hinterdobler J; Li X; Khangholi D; Hettwer J; Gräßer C; Dutsch A; Schunkert H; Kessler T; Sager HB
    Front Immunol; 2022; 13():898690. PubMed ID: 35860249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory Therapeutics and Coronary Artery Disease.
    Eghtedari B; Roy SK; Budoff MJ
    Cardiol Rev; 2023 Mar-Apr 01; 31(2):80-86. PubMed ID: 35471811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
    Banach M; Penson PE
    Curr Atheroscler Rep; 2021 May; 23(7):32. PubMed ID: 33970350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine for the treatment of cardiovascular diseases: old drug, new targets.
    Andreis A; Imazio M; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):1-8. PubMed ID: 32858634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches.
    Tsioufis P; Theofilis P; Tsioufis K; Tousoulis D
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes].
    Di Fusco SA; Imazio M; Rizzello V; Gatto L; Spinelli A; Aquilani S; Riccio C; Caldarola P; Nardi F; De Luca L; Gulizia MM; Gabrielli D; Oliva F; Colivicchi F
    G Ital Cardiol (Rome); 2023 Aug; 24(8):665-674. PubMed ID: 37492875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.